Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial.
- DOI
- 10.1016/s1474-4422(26)00241-3
- Published
- 2026 Sep
- Container
- The Lancet. Neurology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-26-00241-3,
title = {Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial.},
author = {van der Knaap MS and Verbeek RJ and van Voorst RJ and Gonzato E and Stellingwerff MD and Voermans MMC and Postema MC and Dekker H and van den Berg E and Steenweg ME and Bet PM and Bartelink IH and Teunissen CE and Abbink TEM and Berkhof J and van Eekelen R and Wolf NI},
year = {2026},
journal = {The Lancet. Neurology},
doi = {10.1016/s1474-4422(26)00241-3},
url = {https://doi.org/10.1016/s1474-4422(26)00241-3}
}RIS
TY - JOUR TI - Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial. AU - van der Knaap MS AU - Verbeek RJ AU - van Voorst RJ AU - Gonzato E AU - Stellingwerff MD AU - Voermans MMC AU - Postema MC AU - Dekker H AU - van den Berg E AU - Steenweg ME AU - Bet PM AU - Bartelink IH AU - Teunissen CE AU - Abbink TEM AU - Berkhof J AU - van Eekelen R AU - Wolf NI PY - 2026 JO - The Lancet. Neurology DO - 10.1016/s1474-4422(26)00241-3 UR - https://doi.org/10.1016/s1474-4422(26)00241-3 ER -
APA
MS, V. D. K., RJ, V., RJ, V. V., E, G., MD, S., MMC, V., MC, P., H, D., E, V. D. B., ME, S., PM, B., IH, B., CE, T., TEM, A., J, B., R, V. E., & NI, W. (2026). Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(26)00241-3
Source records
- pubmed · retrieved 2026-09-26T11:47:50.493Z